Alimta

(Pemetrexed)

  • Infusion (IV)
  • Malignant mesothelioma of pleura
  • In combination with cisplatin in patients who are not candidates for surgical resection. Non-small cell lung cancer
  • Nonsquamous
  • Locally advanced or metastatic.
Back to: Full Site NavigationSkip to: side effects sectionSkip to: What to expect sectionSkip to: Risks and warnings sectionSkip to: Tips from users and pharmacists
Skip Upsides & Downsides section. Skip to side effects section.
No lower cost generic available

Save on your next Alimta (Pemetrexed) prescription

Be sure you’re getting the lowest price for your medication, even if you have insurance.

Skip side effects sections. Skip to What to Expect and Pharmacists Tips section.

Side effects for Alimta (Pemetrexed)

From clinical trials of Alimta / Non-small cell lung cancer Grade 3-4 ( 830)

  • Low white blood cellsLow white blood cells15% for Alimta vs.0% for placebo
  • NauseaNausea7% for Alimta vs.0% for placebo
  • FatigueFatigue7% for Alimta vs.0% for placebo
  • Low red blood cellsLow red blood cells6% for Alimta vs.0% for placebo
  • VomitingVomiting6% for Alimta vs.0% for placebo
  • Low white blood cellsLow white blood cells5% for Alimta vs.0% for placebo
  • ThrombocytopeniaThrombocytopenia4% for Alimta vs.0% for placebo
  • Loss of appetiteLoss of appetite2% for Alimta vs.0% for placebo
  • Creatinine elevationCreatinine elevation1% for Alimta vs.0% for placebo
  • ConstipationConstipation1% for Alimta vs.0% for placebo

Manufacturers don’t say how common these side effects are

  • Dyspepsia/heartburn
  • Hair loss or baldness
  • Neuropathy-sensory
  • Rash/desquamation
  • Taste disturbance

Tips from pharmacists and people taking Alimta (Pemetrexed)

Final section. Do you want to return to drug navigation?
The FDA category for this medication is D. It is advised that you: Weigh risks vs. benefits
Pregnancy